Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
US6995183B2 · kind B2 · utility
90Cited by
49References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2004 |
| Grant date | Feb 7, 2006 |
| Priority date | — |
| Expiry date | Nov 26, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/74
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided having the formula (I) Further provided are methods of using such compounds for the treatment of diabetes and related diseases, and to pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.